Bristol-Myers Squibb Co
BMY · Health Technology · Pharmaceuticals: Major · US
32,500 employees · bms.com
About
Bristol-Myers Squibb Co is a global biopharmaceutical company focused on the research, development, and production of prescription drugs and biosimilars for the treatment of serious diseases. The company is headquartered in New York, USA, and employs approximately 30,000 people worldwide.
Annual results
Reported figures, USD · revenue down 0.2% in 2025
| Year | Revenue | Net income | Net margin | Free cash flow |
|---|---|---|---|---|
| 2025 | 48.2B | 7.1B | 14.6% | 12.8B |
| 2024 | 48.3B | -8.9B | -18.5% | 13.9B |
| 2023 | 45.0B | 8.0B | 17.8% | 12.7B |
| 2022 | 46.2B | 6.3B | 13.7% | 11.9B |
| 2021 | 46.4B | 7.0B | 15.1% | 15.2B |
Dividends per share
2026 2.52 USD2025 2.48 USD2024 2.40 USD2023 2.28 USD2022 2.16 USD
BMY in MarketPulse
The live chart with RSI and moving averages, the price, news, signals and price alerts for Bristol-Myers Squibb Co are inside MarketPulse — currently in private beta.
Company data by Eulerpool. Logos provided by Elbstream. Reported figures, not investment advice.